Comparison of colorimetric and electrochemical (Easy Touch GCU Meter) methods for determination of blood uric acid in clinical practice in patients with gout and hyperuricemia (data from a pilot study)
Open Access
- 17 October 2023
- journal article
- research article
- Published by IMA Press, LLC in Modern Rheumatology Journal
- Vol. 17 (5) , 87-91
Abstract
Hyperuricemia (HU) is a condition caused by an increase in serum uric acid (UA) levels above 360 μmol/l. Often HU is asymptomatic, but under the influence of genetic and environmental factors, attacks of peripheral arthritis (gout) may occur. Remission of gout is achieved by normalization of UA serum levels, which can be determined by a colorimetric or electrochemical method, although the latter is not currently commonly used in clinical practice to control UA levels. Objective: to compare the standard colorimetric and electrochemical methods (Easy Touch GCU Meter) for monitoring UA levels. Material and methods. 30 gout patients were included in the study. This group included subjects with current/anamnestic asymptomatic HU andpatients with a confirmed diagnosis of gout (ACR/EULAR 2015 criteria). The examination included a general examination, history taking, and laboratory testing. The determination of UA level by the colorimetric method in venous blood serum was performed no later than 5 minutes after collection, and the determination of UA level in fresh whole capillary blood from the fingertip by the electrochemical method (Easy Touch GCU Meter) – immediately after collection. Results and discussion. The average values of UA blood level determined by the two compared methods differed by 13.9 μmol/l (3.9 % with respect to the colorimetric method). The high value of the correlation coefficient (r = 0.86) indicates a close linear relationship between the compared results and their good agreement. The method is also applicable in patients with achieved normouricemia. Conclusions. The method of electrochemical determination of UA level in subjects with HU and gout can be used in real clinical practice for self-monitoring.Keywords
This publication has 11 references indexed in Scilit:
- Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With GoutThe Journal of Rheumatology, 2022
- Impact of urate-lowering therapy on quality of life indicators in patients with goutModern Rheumatology Journal, 2021
- 2020 American College of Rheumatology Guideline for the Management of GoutArthritis Care & Research, 2020
- Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of goutAnnals of the Rheumatic Diseases, 2019
- Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapyTerapevticheskii arkhiv, 2019
- Management of gout and hyperuricemia: Multidisciplinary consensus in TaiwanInternational Journal of Rheumatic Diseases, 2018
- 2016 updated EULAR evidence-based recommendations for the management of goutAnnals of the Rheumatic Diseases, 2017
- GOUT CLASSIFICATION CRITERIA (ACR/EULAR GUIDELINES)Rheumatology Science and Practice, 2015
- Time course of changes in the clinical manifestations of gout in men: Data of a 7-year retrospective follow-upTerapevticheskii arkhiv, 2015
- HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)Rational Pharmacotherapy in Cardiology, 2014